PALO ALTO, Calif., Jan. 25, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the launch of GS1-R™, the first commercially available medium to enable the derivation, maintenance and growth of true (germline competent) rat embryonic stem (ES) cells. GS1-R, the latest addition to the Company’s SC Proven® line of specialty cell culture products, is expected to have significant utility in the creation of genetically engineered rat models of human disease for use in academic, medical and pharmaceutical research.
